Thursday, July 14, 2011
For Some Prostate Cancer Patients, Combo Treatment Improves Survival (HealthDay)
WEDNESDAY, July 13 (HealthDay News) --
For men who have prostate cancer that's considered 'intermediate risk,' radiation plus four months of hormone therapy appears to improve survival, a new study finds.
Researchers found that patients with low-risk prostate cancer did not need hormone therapy because the chance they would survive with radiation alone was already almost 99 percent.
For patients with high-risk prostate cancer, using hormone therapy for just a short while is not effective. We know from other studies that short-term androgen deprivation therapy isn't enough. You need to give long-term androgen deprivation therapy in addition to radiation to have the best results.
For patients with early, localized cancer of the prostate who were treated with radiation therapy, [by] adding short-term androgen deprivation therapy, we improved their cure rates and increased their chance of living 10 years from 57 percent to 62 percent," said lead researcher Dr. Christopher U. Jones, from Radiological Associates of Sacramento, Calif.
For Some Prostate Cancer Patients, Combo Treatment Improves Survival
Friday, July 1, 2011
Life after prostate surgery worse than men expect
NEW YORK (Reuters Health) -
Nearly half of men who undergo surgery to treat prostate cancer find themselves with greater incontinence problems and less sexual function than they had anticipated, according to a new poll.
About half of men expected that they would have the same function after surgery as before, and 17 percent of men anticipated better sexual function after the surgery.
Men's unrealistic expectations can be a double-edged sword. On the one side, optimism is known to help people heal, but on the other side, it may ultimately lead to disappointment when adjusting to a long term disability.
Life after prostate surgery worse than men expect
"
Nearly half of men who undergo surgery to treat prostate cancer find themselves with greater incontinence problems and less sexual function than they had anticipated, according to a new poll.
About half of men expected that they would have the same function after surgery as before, and 17 percent of men anticipated better sexual function after the surgery.
Men's unrealistic expectations can be a double-edged sword. On the one side, optimism is known to help people heal, but on the other side, it may ultimately lead to disappointment when adjusting to a long term disability.
Life after prostate surgery worse than men expect
Friday, June 24, 2011
No sign scans after testicle cancer cause new tumors
No sign scans after testicle cancer cause new tumors:
"NEW YORK (Reuters Health) - Follow-up scans after treatment for testicular cancer don't appear to put men at higher risk of new tumors, researchers have found.
Overall, 14 percent of some 2,500 men who received multiple follow-up scans developed new tumors in the scanned area over the decade following their diagnosis. And those who received the most radiation were at no higher risk.
"Even with those incredibly high doses of diagnostic radiation, we did not identify any association between this exposure and an increased risk of cancers," study author Dr. Carl van Walraven at the Ottawa Health Research Institute told Reuters Health.
One concern with the findings, however, is that the researchers didn't follow the men very long, said Dr. David Brenner, a radiation expert at Columbia University Medical Center in New York, who was not involved in the new work.
On average, the men were only 35 when diagnosed with testicular cancer, and half were tracked for 11 years or less. Yet most radiation-induced cancers in young men "will actually appear 10 to 40 years post-radiation," said Brenner.
No sign scans after testicle cancer cause new tumors
"
"NEW YORK (Reuters Health) - Follow-up scans after treatment for testicular cancer don't appear to put men at higher risk of new tumors, researchers have found.
Overall, 14 percent of some 2,500 men who received multiple follow-up scans developed new tumors in the scanned area over the decade following their diagnosis. And those who received the most radiation were at no higher risk.
"Even with those incredibly high doses of diagnostic radiation, we did not identify any association between this exposure and an increased risk of cancers," study author Dr. Carl van Walraven at the Ottawa Health Research Institute told Reuters Health.
One concern with the findings, however, is that the researchers didn't follow the men very long, said Dr. David Brenner, a radiation expert at Columbia University Medical Center in New York, who was not involved in the new work.
On average, the men were only 35 when diagnosed with testicular cancer, and half were tracked for 11 years or less. Yet most radiation-induced cancers in young men "will actually appear 10 to 40 years post-radiation," said Brenner.
No sign scans after testicle cancer cause new tumors
Wednesday, June 22, 2011
Smoking makes prostate cancer deadlier: U.S. study
Smoking makes prostate cancer deadlier:
U.S. study: "CHICAGO (Reuters) -
Smoking increases the risk that men who develop prostate cancer will die from their disease, U.S. researchers said on Tuesday.
"We compared current smokers to never smokers. Compared to never smokers, current smokers had a 61 percent increased risk of dying of prostate cancer, as well as a 61 percent increased risk of having their cancer return,"
Compared with current smokers, men who had quit for 10 or more years had about the same risk of dying from their prostate cancer as those who had never smoked, Kenfield and colleagues found.
"
U.S. study: "CHICAGO (Reuters) -
Smoking increases the risk that men who develop prostate cancer will die from their disease, U.S. researchers said on Tuesday.
"We compared current smokers to never smokers. Compared to never smokers, current smokers had a 61 percent increased risk of dying of prostate cancer, as well as a 61 percent increased risk of having their cancer return,"
Compared with current smokers, men who had quit for 10 or more years had about the same risk of dying from their prostate cancer as those who had never smoked, Kenfield and colleagues found.
Tuesday, June 21, 2011
New cancer vaccine for Prostate Cancer
New method tested as cancer vaccine:
"BBC News has reported that a vaccine offers hope for prostate cancer sufferers. The broadcaster reported on a new approach to developing cancer vaccines in which “DNA from healthy cells was used to create a vaccine which cured 80% of mice”.
"BBC News has reported that a vaccine offers hope for prostate cancer sufferers. The broadcaster reported on a new approach to developing cancer vaccines in which “DNA from healthy cells was used to create a vaccine which cured 80% of mice”.
It is far too early to suggest that this experimental study offers hope for a vaccine against prostate cancer or any other cancer.
Thursday, June 16, 2011
Impotence Linked to Restless Legs Syndrome (HealthDay)
Impotence Linked to Restless Legs Syndrome
(HealthDay)
HealthDay - WEDNESDAY, June 15 (HealthDay News) --
Men who struggle with restless legs syndrome face a higher risk of impotence, a new study suggests.
Men who experienced restless legs syndrome symptoms up to 14 times a month were 68 percent more likely to struggle with erectile dysfunction, the study found.
The research was presented at SLEEP 2011, the annual meeting of the Associated Professional Sleep Societies, in Minneapolis. Because the study was presented at a medical meeting, the conclusions should be viewed as preliminary until published in a peer-reviewed journal.
(HealthDay)
HealthDay - WEDNESDAY, June 15 (HealthDay News) --
Men who struggle with restless legs syndrome face a higher risk of impotence, a new study suggests.
Men who experienced restless legs syndrome symptoms up to 14 times a month were 68 percent more likely to struggle with erectile dysfunction, the study found.
The research was presented at SLEEP 2011, the annual meeting of the Associated Professional Sleep Societies, in Minneapolis. Because the study was presented at a medical meeting, the conclusions should be viewed as preliminary until published in a peer-reviewed journal.
Friday, June 10, 2011
Prostate drugs raise risk of prostate cancer: FDA
Prostate drugs raise risk of prostate cancer: FDA:
"WASHINGTON (Reuters) - A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday.
"
"WASHINGTON (Reuters) - A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday.
The drugs in this group include Merck & Co's Proscar and GlaxoSmithKline's Avodar and Jalyn, as well as Merck's Propecia, which is approved to treat male pattern hair loss.
The Food and Drug Administration said it revised the labels on all such drugs, called 5-alpha reductase inhibitors (5-ARI), to include the risk after reviewing two large studies.
However, they also said the drugs' benefits outweigh the risks.
Subscribe to:
Posts (Atom)